Intermediate Medical Acquisition Course (IMAC) Training in support of the Operational Medicine (OPMED)

The Defense Health Agency (DHA) Operational Medicine division is seeking contractor support to develop and deliver the Intermediate Medical Acquisition Course (IMAC), a comprehensive training program consisting of two distinct offerings: a 40-hour DAU-certified medical acquisition course for acquisition personnel and a 16-22 hour leadership-focused course for senior leaders. The primary course must align with Defense Acquisition University Program Management Level II learning objectives and focus on medical acquisition processes, including FDA-regulated product development, medical devices, drugs, and vaccines, while supporting Integrated Product Teams. Key requirements include DAU certification compliance, instructor qualifications, delivery of course materials 15 days prior to instruction, maintenance of attendance rosters, post-course evaluations, and issuance of training certificates. The RFI requests capability statements from interested contractors by January 21, 2026 at 12:00 PM ET, with responses limited to ten pages and must include company details, unique entity identification, current government contract vehicles, and relevant experience demonstrating capabilities aligned with the draft Performance Work Statement. Contractors must be registered in the System for Award Management (SAM) to be considered.

This procurement includes no set-aside designation and carries no identified incumbent contractor or award value range in the available documentation. The contract envisions six annual offerings of the primary 40-hour course serving 25-30 attendees per session, with the leadership course offered two to four times annually. Courses may be delivered in-person or virtually at DOD facilities, primarily at Fort Detrick, with provisions for Other Direct Costs (ODCs) such as travel and materials reimbursable under FAR Part 31 regulations. The RFI is issued for information and planning purposes only and does not guarantee a future solicitation or contract award, though it indicates the agency's intent to move toward formal procurement activities. The response deadline of January 21, 2026 provides industry a one-week window to submit capability statements and establish preliminary interest.